Shiseido expects the transfer to be completed between the fourth quarter of 2026 and the first quarter of 2027.

CHINA – Shiseido has agreed to sell its entire stake in Shiseido Liyuan Cosmetics Co., Ltd. (SLC), the China-only maker and marketer of the Aupres brand, to an investor consortium led by IDG Capital at an undisclosed price.
Shiseido approved the transaction and signed a legally binding equity-transfer agreement with the buyers, along with a legally binding transitional services agreement with SLC.
The sale covers the Aupres business, SLC’s Beijing factory, and its production equipment, while Shiseido said its China and travel-retail operations will continue, with resources redirected toward priority brands, portfolio strengthening, research and development, new growth areas, and digital and AI initiatives.
The buyers consist of three entities: two special-purpose vehicles established by funds managed by IDG Capital and a limited partnership formed primarily by SLC’s incoming management team.
Sunrise Winning Limited, a Cayman Islands vehicle wholly owned by IDG Breyer Capital Fund L.P., will acquire 80.66% of SLC; Zhuhai Pulai Management Consulting Partnership, a limited partnership established by a China-based renminbi fund, will take 14.34%; and Shanghai Bozhiyuan Enterprise Management Partnership, formed by SLC’s new management team, will receive the remaining 5%.
Together, the two IDG-related vehicles will hold 95% of the company, while the management partnership will hold 5%. Shiseido did not disclose the limited partners behind the two partnerships and said it has no capital, personnel, or trading relationship with any of the buyers, none of which is a related party.
SLC was established in 1991 as a joint venture with Beijing Liyuan, a company linked to Beijing municipal government-owned Yiqing Group, and has manufactured and sold Aupres cosmetics in China since 1994.
The third joint-venture agreement was due to expire in December 2026, and the parties agreed not to renew it. On September 1, 2026, the Shiseido Group acquired Beijing Liyuan’s 35% stake, making SLC wholly owned by the Shiseido Group before the planned sale.
For the year ended December 2025, SLC reported sales of RMB 868 million (USD 130/2 million), under IFRS, along with an operating loss of RMB 55 million(USD 8.25 million)
Its loss attributable to owners of the parent was RMB 41 million(USD 6.15 million).
At the end of 2025, SLC had total assets of RMB 900 million (USD 135 million) and equity of RMB 618 million 9USD 92.71 million)
Shiseido did not reveal the sale price because of confidentiality obligations in the transfer agreement.
It said the price was determined through due diligence and arm’s-length negotiations between the parties.
Shiseido explained that SLC requires continued investment in product innovation and digital capabilities amid changing market conditions and competition, and that, after assessing the business’s sustainability and its own investment priorities, transferring it to IDG was the best option for its future development and stakeholders.
It described IDG as an international private-equity firm with extensive experience in the consumer sector.
To ensure a smooth handover, Shiseido will license certain intellectual-property rights needed to operate the business.
For a defined period after completion, it will also support new-product development, provide technical assistance to maintain a stable supply of existing products, and continue supplying raw materials and selected products, helping preserve innovation, product quality, and business continuity.
The transaction remains subject to required regulatory approvals in relevant markets, including China, and other customary closing conditions.
Shiseido also said the estimated impact on its December 2026 consolidated results has already been included in the full-year forecast revision it issued on November 10, 2026.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.